Cover Image

Impact of type 2 diabetes on oncologic outcomes of hepatocellular carcinomas in non-cirrhotic, non-alcoholic steatohepatitis: a matched-pair analysis

Non-alcoholic steatohepatitis (NASH) associated hepatocellular carcinomas (NASH-HCC) are increasing. NASH-HCC often develops in the fibrotic liver. Several analyses report conflicting results regarding the outcome of non-cirrhotic NASH-HCC. Furthermore, type 2 diabetes (T2D) is considered a risk fac...

Full description

Saved in:
Bibliographic Details
Main Authors: Billeter, Adrian (Author) , Müller, Philip C. (Author) , Albrecht, Thomas (Author) , Rössler, Stephanie (Author) , Löffler, Moritz (Author) , Murtha-Lemekhova, Anastasia (Author) , Mehrabi, Arianeb (Author) , Müller, Beat P. (Author) , Hoffmann, Katrin (Author)
Format: Article (Journal)
Language:English
Published: 2021
In: Journal of gastrointestinal surgery
Year: 2021, Volume: 25, Issue: 5, Pages: 1193-1202
ISSN:1873-4626
DOI:10.1007/s11605-020-04628-0
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s11605-020-04628-0
Get full text
Author Notes:Adrian T. Billeter, Philip C. Müller, Thomas Albrecht, Stephanie Roessler, Moritz Löffler, Anastasia Lemekhova, Arianeb Mehrabi, Beat P. Müller-Stich, Katrin Hoffmann
Description
Summary:Non-alcoholic steatohepatitis (NASH) associated hepatocellular carcinomas (NASH-HCC) are increasing. NASH-HCC often develops in the fibrotic liver. Several analyses report conflicting results regarding the outcome of non-cirrhotic NASH-HCC. Furthermore, type 2 diabetes (T2D) is considered a risk factor for poor survival. The aim of this study was to investigate oncological outcomes of non-cirrhotic NASH-HCC and the impact of T2D.
Item Description:Published online: 6 May 2020
Gesehen am 31.08.2021
Physical Description:Online Resource
ISSN:1873-4626
DOI:10.1007/s11605-020-04628-0

Similar Items